Reuters reveals Tens of millions of J&J COVID-19 shots sit at Baltimore factory - Reuters News Agency
Health

Reuters reveals Tens of millions of J&J COVID-19 shots sit at Baltimore factory

Reuters broke the news that an estimated 30 million to 50 million doses of Johnson & Johnson’s COVID-19 vaccine made earlier this year sit idle in Emergent BioSolutions Inc’s plant in Baltimore, awaiting a green light from U.S. regulators to ship. A source said Emergent is waiting for the U.S. Food and Drug Administration to approve release of those doses. Emergent shares opened nearly 1% higher following the Reuters report.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Business & Finance
Regions: North America
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Johnson & Johnson coronavirus disease (COVID-19) vaccine is seen at the OSU Wexner Medical Center in Columbus, Ohio, U.S. March 2, 2021. REUTERS/Gaelen Morse NO ARCHIVES. NO SALES.
Sign up for email updates
Subscribe
Sign up for email updates